{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibtyzd5pfeul5a7ql4kdqfv2qlhr2tpjg764zvkezhgi5vcwntjie",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mk6rotw6c6l2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigtb4wgphvhmc7gp634227kgx3f6e3lmw6xtbyuxixmq7ljzzibqe"
    },
    "mimeType": "image/jpeg",
    "size": 119767
  },
  "path": "/news/2026-04-therapy-aggressive-childhood-adult-cancers.html",
  "publishedAt": "2026-04-23T15:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in preclinical studies that bring the breakthrough closer to human clinical trials. The therapy targets a protein called IL1RAP, which is found on the surface of certain cancer cells, but is largely absent from normal tissues. By linking a cancer-killing drug to an antibody that recognizes this protein, the team created an antibody-drug conjugate that delivers treatment directly to cancer cells while sparing healthy tissues.",
  "title": "New targeted therapy shows promise against aggressive childhood and adult cancers"
}